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Abstract
BACKGROUND/OBJECTIVES—To combat iron and other micronutrient deficiencies, the 
Ministry of Health of the Kyrgyz Republic launched a regional Infant and Young Child Nutrition 
(IYCN) program in 2009, which included promotion of home fortification with micronutrient 
powder (MNP) containing iron (12.5 mg elemental iron), vitamin A (300 μg) and other 
micronutrients. Every 2 months children aged 6–24 months were provided 30 sachets to be taken 
on a flexible schedule. The objective was to assess biochemical indicators of iron and vitamin A 
status among children aged 6–24 months at the baseline and follow-up surveys.
SUBJECTS/METHODS—Cross-sectional representative cluster surveys were conducted in 
2008 (n =571 children) and 2010 (n =541). Data collected included measurement of hemoglobin, 
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serum ferritin, soluble transferrin receptor (sTfR), retinol-binding protein, C-reactive protein 
(CRP) and α1-glycoprotein acid (AGP).
RESULTS—Among all children, declines were observed in the prevalence of: anemia, 50.6% 
versus 43.8% (P =0.05); total iron deficiency (either low ferritin or high sTfR), 77.3% versus 
63.7% (P<0.01); and iron deficiency anemia, 45.5% versus 33.4% (P<0.01). Among children 
without inflammation as measured by CRP and AGP, similar declines were observed, but only 
declines in total iron deficiency and iron deficiency anemia reached statistical significance. 
Among all children and those without inflammation, the prevalence of vitamin A deficiency 
remained the same.
CONCLUSIONS—One year after the introduction of home fortification with MNP, within a 
larger IYCN program, the prevalence of anemia, iron deficiency and iron deficiency anemia 
declined, but vitamin A deficiency remained unchanged.
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INTRODUCTION
Anemia is an important public health problem in the Kyrgyz Republic. In the 1997 
Demographic and Health Survey, the prevalence of anemia was 50% in children 6–36 
months of age and 38% in women of reproductive age.1 Non-nationally representative 
studies undertaken since 1997 suggest that anemia remains a public health problem, despite 
various campaigns.2 To address iron and other micronutrient deficiencies, the Ministry of 
Health (MOH) launched a pilot Infant and Young Child Nutrition (IYCN) program, which 
included a nutrition education program to encourage breastfeeding and appropriate 
complementary feeding, and distribution of micronutrient powder (MNP) for consumption 
by children 6–24 months of age.
MNP has been shown to prevent and reduce anemia. A systematic review of efficacy and 
effectiveness studies, in which home fortification (including MNP, crushable tablets and fat-
based products) of complementary foods was the primary intervention for anemia 
prevention, concluded that the average effect was an increase in hemoglobin by 8 g/l and a 
21 percentage point (PP) decrease in the prevalence of anemia in children 6–24 months of 
age.3 A Cochrane review evaluated effects of home fortification of foods with MNP 
containing at least iron, zinc and vitamin A;4 compared with no intervention or placebo, 
home fortification with MNP showed a 31% relative reduction in anemia and a 51% relative 
reduction in iron deficiency.
Based on the success of these studies, MNP programs are being implemented on a 
population level in many countries around the world.5 Although the efficacy of MNP 
programs has been well established in numerous trials, effectiveness studies of MNP 
programs in the peer-reviewed literature are relatively few, and have been conducted among 
special populations such as refugee settings6,7 or food aid recipients.8 Two previous studies 
conducted in a general population were of 2–6 months duration.2,9 With one exception,9 
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none have measured iron deficiency or accounted for effects of inflammation, which can 
influence concentration of biomarkers.10,11
We used a pre-post survey design to examine the prevalence of anemia, iron deficiency, iron 
deficiency anemia and vitamin A deficiency before and after the initiation of a large-scale 
integrated IYCN/MNP program, taking inflammation status into account.
MATERIALS AND METHODS
IYCN/MNP program
The program included both a community-based nutrition education initiative and 
distribution of MNP through government primary health-care clinics. The community-based 
nutrition education program was implemented in the rural areas of the Talas Oblast 
(province) of the Kyrgyz Republic. The education program was designed to improve diet 
during pregnancy, encourage breastfeeding until 24 months of age (exclusive breastfeeding 
until 6 months of age) and improve complementary feeding. The nutrition education 
program of the MOH was implemented by village health committees, which consist of 
volunteers who are trained on public health and nutrition issues and who share their 
knowledge through peer-to-peer interactions.
The education program on infant and young child feeding began in May 2008. One year 
later in June 2009, the MOH launched a program to distribute MNP through government 
primary health-care centers at no cost to all children 6–24 months of age. Primary health-
care providers distributed MNP, instructed caretakers on proper use and distributed 
informational materials. The MNP was packaged in individual dose sachets that contained 
12.5 mg of elemental iron (as microencapsulated ferrous fumarate); 160 μg of folic acid; 300 
μg of vitamin A (retinol acetate); 30 mg of vitamin C (ascorbic acid); and 5 mg of zinc (zinc 
gluconate). Procured through United Nations Children’s Fund, the product was required to 
meet strict quality control requirements.12 As children reached 6 months of age, they were 
eligible to receive MNP at their primary health-care clinic and were invited to enroll during 
their routine well-child checkup. In some cases, primary health-care providers visited the 
family at home to recruit children. Trained health-care providers distributed MNP either at 
the health clinics or at the household. Using a ‘flexible administration’ approach, caretakers 
were instructed to give the MNP according to any schedule they wished, as long as they 
used all 30 sachets in 2 months. Caretakers were given an instructional flier and a reminder 
card with the date they should receive their next package.
Before the launch of the program, formative research was conducted. Focus group 
discussions were held with a sample of caretakers and primary health-care providers. 
Instructional and promotional materials were prepared for distribution. A logo and 
accompanying message (‘For the health and mind of your child’) were developed. Village 
health committees were encouraged to inform caretakers about MNP and to ask them to 
bring their children to the health-care provider to enter into the program. Village health 
committees delivered key messages with the aid of flip charts and brochures and also 
distributed a children’s book. Primary health-care providers were solely responsible for 
distributing MNP and, with the aid of instructional brochures, informing caretakers about 
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appropriate preparation and use. The program also enlisted the strong support of both the 
local governmental authorities and the mass media through provision of press-kits at the 
kickoff celebration and the airing of advertisements, jingles and informational interviews on 
the widely popular regional public radio station.
Survey design and sampling
A baseline survey was conducted in June/July 2008, and a follow-up survey was conducted 
in July/August 2010, approximately one year after MNP distribution began in June 2009.
Based on a pre- and post-survey design with independent samples (estimated design effect = 
2), we initially calculated that a target sample size of 540 participants would be needed for 
each survey (power = 0.80 and alpha = 0.05). This sample size was based on the number of 
participants necessary to detect a relative decline in the prevalence of anemia and iron 
deficiency of 20%. To adjust for nonresponse, 20 children were initially included in each 
cluster (30 clusters). Because initial response was lower than expected in the 2008 survey, 
the coordinator increased the number of children selected for interview to 22 in each cluster. 
This number was further increased to 24 in the 2010 survey to account for both the higher 
than expected nonresponse and the absence due to migration observed in the 2008 survey. 
The sample frame for the 2008 survey was children 6–24 months living in rural Talas; the 
sample frame for the 2010 survey was children 6–24 months living in Talas (26 rural 
clusters and 4 urban clusters).
For both surveys a two-stage cluster sampling design was used. All children living in the 
Kyrgyz Republic are assigned to a primary health-care center based on location of residence. 
Each primary health-care center was designated as a primary sampling unit. In the first stage 
of sampling, based on the number of preschool children assigned to each health center, 30 
primary sampling units were selected through probability proportionate to size cluster 
sampling. In the second stage, a random number list was employed to select children from 
each cluster.
Surveys were exempted from review by the Institutional Review Board of CDC as the 
surveys were considered public health practice. The Ethics Committee under the Department 
of Drug Provision and Medical Equipment of the Kyrgyz Republic approved the survey 
protocols. In both the surveys, the field team informed children’s caretakers about the survey 
and asked them to provide written informed consent for participation. A timeline for the 
IYCN/MNP intervention and surveys is shown in Figure 1.
Data collection
Three field teams collected data for both surveys. In the 2008 survey, data were collected 
during June and July, and in the 2010 survey, data were collected during July and August. 
Selected children were invited to come to their health-care center on a predetermined day. If 
children did not arrive, survey team personnel visited the home.
Both the 2008 and 2010 questionnaires were written in English and then translated into the 
Kyrgyz and Russian languages.
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Hemoglobin was assessed using the HemoCue photometric instrument (Model 301, 
HemoCue AB, Angelholm, Sweden). Laboratory personnel collected capillary blood 
samples through a finger stick. After the first drop, the finger was wiped clean, and the 
second drop was drawn into a HemoCue cuvette. Afterwards, 500 μl of blood was collected 
in a Microtainer. Biochemical analysis was conducted using the ‘sandwich assay’.13 The 
biochemical indicators measured iron status (serum ferritin, soluble transferrin receptor 
(sTfR)), vitamin A (retinol-binding protein (RBP)), inflammation (C-reactive protein (CRP) 
and α1-glycoprotein acid (AGP)).
Anemia was defined as an altitude-adjusted hemoglobin concentration of <11.0 g/dl.14 Total 
iron deficiency was defined as either decreased serum ferritin concentration (<12 μg/l) or 
increased sTfR levels (>8.3 mg/l). Iron deficiency anemia was defined as having both a low 
hemoglobin value and either low serum ferritin or high sTfR.
RBP was used as an indicator of vitamin A status.15 Based on a comparison of RBP and 
plasma retinol on a subsample of participants by the CDC Nutrition Laboratory, an RBP 
concentration less than 0.71 μmol/l was determined as the cutoff for vitamin A deficiency 
(personal communication, Rosemary Schleicher).
As serum ferritin and RBP are acute-phase reactants, two indicators of inflammation, CRP 
and AGP, were also measured.10,11 Inflammation was considered present if either was 
elevated (CRP>5.0 mg/l or AGP>1.0 g/l). All biochemical results are presented for the total 
population and the population without inflammation.
Data analysis
As the 2008 survey included only children living in rural areas, in the 2010 survey, only 
children living in the 26 rural clusters were included in this analysis. Because children were 
first enrolled in the program either at the first well-child checkup after they reached 6 
months of age or when the health-care worker visited their home, we expected that children 
6–11 months of age would have had a shorter degree of exposure to the program than older 
children. Therefore, analyses were stratified by age (6–11 months and 12–24 months of 
age). Data analysis was conducted using Stata (version 10.0, StataCorp, College Station, 
TX, USA). Pearson χ2 tests were run using methods that account for the design of the two 
surveys (standard errors were adjusted for the cluster survey design).
RESULTS
For the 2008 survey, 642 children were invited to participate; of those, 571 participated 
(88.9%). For the 71 children who did not participate, reasons for non-participation included: 
permanently moved (n =18), family refused (n =3), temporary migration or absence from the 
home (n =34) and other (n =16). Of those who participated, 571 had hemoglobin 
measurements and 569 had information on other biochemical indicators.
For the 2010 survey, 624 children from rural clusters were invited to participate; of those, 
543 participated (87.0%). For the 81 children who did not participate, reasons for non-
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participation included: permanently moved (n =6), family refused (n =5), temporary 
migration or absence from the home (n =58) and other (n =12). Of those who participated, 
541 had acceptable hemoglobin measurements and 485 had information on other 
biochemical indicators.
In both surveys, participation was slightly higher in males, but fairly even across age groups. 
Inflammation was present in 42.0% of children in 2008 and 39.0% in 2010 (Table 1).
Among all children, the prevalence of anemia decreased from 50.6 to 43.8% (P =0.05); total 
iron deficiency (as measured by either low ferritin or high sTfR) from 77.3 to 63.7% 
(P<0.01); and iron deficiency anemia (defined as low hemoglobin and either low serum 
ferritin or high sTfR) from 45.5 to 33.4% (P-value<0.01; Table 2). The pattern of decline 
varied by age of the child. Among children 6–11 months of age, significant declines were 
observed only for iron deficiency (as measured by high sTfR). Among children 12–24 
months of age, significant declines were observed for anemia (55.6–44.0%; P =0.01), total 
iron deficiency (84.5–67.2%; P<0.01) and iron deficiency anemia (53.0–34.3%; P <0.01).
Among children without inflammation, the prevalence of anemia decreased from 47.0 to 
40.2% (P =0.13), but the decrease was not statistically significant. Total iron deficiency 
decreased from 79.7 to 67.2% (P<0.01) and iron deficiency anemia decreased from 43.3 to 
34.1% (P =0.02). Among children 6–11 months of age, significant declines were observed 
only for iron deficiency as measured by sTfR. Among children 12–24 months of age, 
significant declines were observed for anemia (54.1–40.8%; P =0.01), total iron deficiency 
(88.5–70.9%; P<0.01) and iron deficiency anemia (52.6–35.0%; P <0.01).
Among all children, the prevalence of vitamin A deficiency was similar in the two surveys 
(19.5% vs 22.1%, P =0.44). Among those without inflammation, the prevalence of vitamin 
A deficiency was also similar (12.4% vs 9.8%, P =0.42).
DISCUSSION
Among all children, the decline in the prevalence of anemia was of borderline statistical 
significance; however, the decline in the prevalence estimates for total iron deficiency and 
iron deficiency anemia were statistically significant. Among children without evidence of 
inflammation, a similar magnitude of decline was observed for anemia and iron deficiency; 
however, only the declines in total iron deficiency and iron deficiency anemia reached 
statistical significance.
The 6.8 PP reduction in anemia observed in our population is similar to the findings of other 
effectiveness studies of home fortification. An earlier study by Lundeen et al2 conducted in 
children 6–36 months living in the Kyrgyz Republic showed a 20-PP reduction in anemia 
(P<0.001) in the treatment group (72% vs 52%) compared with a 3-PP increase in the non-
intervention comparison group (72% vs 75%). In that study, the treatment group received 60 
MNP sachets (12.5 mg iron) to be taken daily over a 2-month period. In a study conducted 
in children 9–24 months of age living in rural Haiti, Menon et al. randomly allocated 
participants in a fortified wheat-soy-blend (WSB) food distribution program to either a 
treatment group that received both WSB and MNP sachets (12.5 mg iron) to be consumed 
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daily over a 2-month period or a control group that received WSB only.8 From baseline to 
follow-up, the treatment group showed a 20-PP reduction (age and sex adjusted) in anemia 
(hemoglobin <100 g/l; 54% vs 24%, P<0.001) and the control group increased 4 PP (39% vs 
43%, P =0.07). In a cluster randomized trial of children 6–11 months in Cambodia 
conducted by Jack et al., children were assigned to either a treatment group that received 
both IYCN and MNP sachets (12.5 mg iron) or a control group that received IYCN alone.9 
At 12 months, compared with the control group, children in the treatment group showed a 
20.6-PP reduction in anemia (84.7% vs 66.7%, P<0.001). In a series of cross-sectional 
surveys conducted in Bhutanese refugee children living in camps in Nepal, Bilukha assessed 
the anemia status of children 13 months before and at 26 months after distribution of MNP 
sachets (10 mg iron), which were to be consumed every other day.7 Among children 6–23 
month of age, a 10-PP lower prevalence of anemia was observed (71.6% vs 61.5%, P<0.05).
We found a statistically significant reduction between the 2008 and 2010 surveys in the 
prevalence of anemia, total iron deficiency and iron deficiency anemia among children 12–
24 months of age, however, this was not the case among children 6–11 months of age. In 
contrast to our findings, the Lundeen study showed no difference in the impact of MNP by 
age group.2 The Menon study showed a larger impact on younger children (6–17.9 months) 
compared with older children (18–21.9 months).8 Although the reason for the differences 
between studies with regard to age impact is unclear, in our population the lesser impact in 
the youngest age group may have been due to delay in enrollment of the youngest children 
in the program leading to shorter treatment time and consequently lower impact.
Several possible factors could contribute to the other (non-age-related) differences in 
findings, including population size, duration of the intervention and adherence. Our 
intervention and the Bilukha refugee study were conducted over a 1- to 2-year period as part 
of a large-scale public health program.7 The study by Jack et al. was conducted over a 6-
month period, whereas the Lundeen and Menon studies were both conducted over a 2-month 
period and were small-scale interventions.2,8,9 With regard to adherence, at our 1-year 
follow-up, 71.2% of children were reported to currently consume the MNP (data not 
shown). In the refugee population, Bilukha found that 90% of children were reported to 
currently consume the MNP at last follow-up. Rather than relying on self-report, other 
studies assessed adherence by counting the number of sachets remaining. On average, 
children consumed between 96%8 and 75% of the sachets.2,9,16
We found that the prevalence of vitamin A deficiency was similar at baseline and follow-up. 
These findings are similar to those of three other studies of home fortification products in 
which there was no significant impact of the intervention on vitamin A status.3,9,17,18 In our 
population, the lack of impact might be partially attributable to concurrent vitamin A 
capsule distribution, the insensitivity of current indicators to assess vitamin A status,19 and 
the relatively low prevalence of vitamin A deficiency in the population without 
inflammation.
This pre-post cross-sectional survey design does not allow determination of causality. 
Although the demographic characteristics were similar between the baseline and follow-up 
surveys, the baseline survey was conducted 1 year before the MNP distribution. Without a 
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comparison population it is not possible to account for the economic and governmental 
changes, which occurred in the 2-year interval between the surveys.20 Furthermore, we 
cannot distinguish the effects of the IYCN nutrition education program from the MNP 
program.
Based on the success of this pilot program, the Kyrgyz Republic will be among the first 
countries in the world to scale up its home fortification program nationwide. Our evaluation 
provides evidence that a large-scale MNP program delivered through the health-care system, 
combined with health education and extensive community mobilization, may have resulted 
in the reduction of anemia and iron deficiency in the Kyrgyz Republic.
Acknowledgments
Both surveys were administered under a cooperative agreement between UNICEF and the Centers for Disease 
Control and Prevention (CDC). The surveys were carried out with support from the Central and Eastern Europe/
Commonwealth of Independent States UNICEF regional office and the Swiss Red Cross. The collaborating partners 
included the Ministry of Health of the Kyrgyz Republic (MOH), the National Statistical Committee of the Kyrgyz 
Republic (NSC), the Talas Oblast Regional Statistics Department and the United Nations Children’s Fund 
(UNICEF)-Kyrgyz Republic country office.
References
1. Institute of Obstetrics and Pediatrics [Kyrgyz Republic], Macro International Inc. Kyrgyz Republic, 
Demographic and Health Survey 1997. Research Institute of Obstetrics and Pediatrics, Ministry of 
Health of the Kyrgyz Republic and Macro International Inc; Calverton, Maryland, USA: 1998. 
2. Lundeen E, Schueth T, Toktobaev N, Zlotkin S, Hyder SM, Houser R. Daily use of Sprinkles 
micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the 
Kyrgyz Republic: a cluster-randomized trial. Food Nutr Bull. 2010; 31:446–460. [PubMed: 
20973465] 
3. Dewey KG, Adu-Afarwuah S. Systematic review of the efficacy and effectiveness of 
complementary feeding interventions in developing countries. Matern Child Nutr. 2008; 4:24–85. 
[PubMed: 18289157] 
4. De-Regil LM, Suchdev PS, Vist GE, Walleser S, Pena-Rosas JP. Home fortification of foods with 
multiple micronutrient powders for health and nutrition in children under two years of age. 
Cochrane Database Syst Rev. 2011; 9:CD008959. [PubMed: 21901727] 
5. World Health Organization. Guideline: Use of Multiple Micronutrient Powders for Home 
Fortification of Foods Consumed by Infants and Children 6–23 Months of Age. World Health 
Organization; Geneva: 2011. 
6. Ndemwa P, Klotz CL, Mwaniki D, Sun K, Muniu E, Andango P, et al. Relationship of the 
availability of micronutrient powder with iron status and hemoglobin among women and children in 
the Kakuma Refugee Camp, Kenya. Food Nutr Bull. 2011; 32:286–291. [PubMed: 22073802] 
7. Bilukha O, Howard C, Wilkinson C, Bamrah S, Husain F. Effects of multi-micronutrient home 
fortification on anemia and growth in Bhutanese refugee children. Food Nutr Bull. 2011; 32:264–
276. [PubMed: 22073800] 
8. Menon P, Ruel MT, Loechl CU, Arimond M, Habicht JP, Pelto G, et al. Micronutrient Sprinkles 
reduce anemia among 9- to 24-mo-old children when delivered through an integrated health and 
nutrition program in rural Haiti. J Nutr. 2007; 137:1023–1030. [PubMed: 17374671] 
9. Jack SJ, Ou K, Chea M, Chhin L, Devenish R, Dunbar M, et al. Effect of micronutrient sprinkles on 
reducing anemia: a cluster-randomized effectiveness trial. Arch Pediatr Adolesc Med. 2012; 
166:842–850. [PubMed: 22801933] 
10. Thurnham DI, McCabe GP, Northrop-Clewes CA, Nestel P. Effects of subclinical infection on 
plasma retinol concentrations and assessment of prevalence of vitamin A deficiency: meta-
analysis. Lancet. 2003; 362:2052–2058. [PubMed: 14697804] 
Serdula et al. Page 8













11. Thurnham DI, McCabe LD, Haldar S, Wieringa FT, Northrop-Clewes CA, McCabe GP. Adjusting 
plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment 
of iron deficiency: a meta-analysis. Am J Clin Nutr. 2010; 92:546–555. [PubMed: 20610634] 
12. de Pee S, Kraemer K, van den Briel T, Boy E, Grasset C, Moench-Pfanner R, et al. Quality criteria 
for micronutrient powder products: report of a meeting organized by the World Food Programme 
and Sprinkles Global Health Initiative. Food Nutr Bull. 2008; 29:232–241. [PubMed: 18947036] 
13. Erhardt JG, Estes JE, Pfeiffer CM, Biesalski HK, Craft NE. Combined measurement of ferritin, 
soluble transferrin receptor, retinol binding protein, and C-reactive protein by an inexpensive, 
sensitive, and simple sandwich enzyme-linked immuno-sorbent assay technique. J Nutr. 2004; 
134:3127–3132. [PubMed: 15514286] 
14. World Health Organization, United Nations University, UNICEF. Iron deficiency anemia 
assessment, prevention, and control- a guide for programme managers. World Health 
Organization; Geneva: 2001. 
15. Gorstein JL, Dary O, Pongtorn, Shell-Duncan B, Quick T, Wasanwisut E. Feasibility of using 
retinol-binding protein from capillary blood specimens to estimate serum retinol concentrations 
and the prevalence of vitamin A deficiency in low-resource settings. Public Health Nutr. 2008; 
11:513–520. [PubMed: 18410697] 
16. Zlotkin S. More proof that home fortification is of value in children with iron deficiency anemia. 
Arch Pediatr Adolesc Med. 2012; 166:869–870. [PubMed: 22945323] 
17. Zlotkin S, Antwi KY, Schauer C, Yeung G. Use of microencapsulated iron(II) fumarate sprinkles 
to prevent recurrence of anaemia in infants and young children at high risk. Bull World Health 
Org. 2003; 81:108–115. [PubMed: 12756979] 
18. Smuts CM, Dhansay MA, Faber M, van Stuijvenberg ME, Swanevelder S, Gross R, et al. Efficacy 
of multiple micronutrient supplementation for improving anemia, micronutrient status, and growth 
in South African infants. J Nutr. 2005; 135:653S–659S. [PubMed: 15735110] 
19. Tanumihardjo SA. Vitamin A: biomarkers of nutrition for development. Am J Clin Nutr. 2011; 
94:658S–665S. [PubMed: 21715511] 
20. Ortiz, I.; Chai, J.; Cummins, M. Escalating Food Prices: The Threat to Poor Households and 
Policies to Safeguard a Recovery for All. UNICEF; New York: 2011. 
APPENDIX. The Kyrgyz Republic Working Group
G Samohleb1, R Donnie Whitehead Jr2, U Mandava✠, KM Sullivan3,4
1Kyrgyz Republic Department of Statistics, Bishkek, Kyrgyz Republic
2Division of Laboratory Sciences, CDC, Atlanta, GA, USA
✠Deceased
3Division of Nutrition, Physical Activity and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers 
for Disease Control and Prevention (CDC), Atlanta, GA, USA
4Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
Serdula et al. Page 9
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Table 1
Characteristics of childrena 6–24 months in rural Talas Oblast, Kyrgyz Republic, 2008 and 2010
Characteristics 2008 2010
n % (95% CI) n % (95% CI)
Gender 571 543
 Male 52.4 (49.1, 55.6) 54.3 (50.0, 58.7)
 Female 47.6 (44.4, 50.9) 45.7 (41.3, 50.0)
Age (months) 571 543
 6–11 35.4 (31.4, 39.3) 32.2 (29.5, 34.9)
 12–17 33.5 (29.1, 37.8) 34.8 (32.0, 37.6)
 18–24 31.2 (27.6, 34.7) 33.0 (29.7, 36.2)
Mother’s educationb (highest level completed) 488 528
 Less than secondary 0.8 (0.0, 2.1) 4.0 (0.3, 7.6)
 Secondary 65.4 (60.5, 70.2) 64.2 (60.1, 68.3)
 Technical 17.4 (13.7, 21.1) 13.4 (10.3, 16.6)
 Higher education 16.4 (12.9, 19.9) 18.4 (14.5, 22.2)
Inflammation status
 Elevated CRP or AGPc 569 42.0 (37.0, 47.0) 485 39.0 (34.4, 43.6)
  Elevated CRP 17.2 (14.4, 20.1) 17.3 (14.1, 20.5)
  Elevated AGP 39.7 (35.0, 44.4) 35.1 (30.3, 39.8)
 No inflammationd 58.0 (53.0, 63.0) 61.0 (56.4, 65.6)
Abbreviations: AGP, α1-glycoprotein acid; CI, confidence interval; CRP, C-reactive protein. 95% CI adjusted for cluster survey design.
a
Calculated for children who had valid measurements for anthropometry, hemoglobin and/or other biochemical indicators (If a child had a valid 
measurement for at least one of these indicators they were included in this description of the sample.).
b
Information on the mother’s education level was not available for all participants with anthropometry and biochemical data.
c
CRP >5.0 mg/l; AGP >1.0 g/l.
d
CRP ≤5.0 mg/l and AGP ≤1.0 g/l.
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